Morpheus8 FDA-approved RF technology with microneedles
Introduction
In the world of aesthetic surgery and anti-aging medicine, innovations continually emerge that promise better results and increased safety for patients. One of the latest and most advanced technologies gaining attention from both experts and patients is Morpheus8. This revolutionary fractional radiofrequency (FRF) technology with microneedles has received approval from the U.S. Food and Drug Administration (FDA) for soft tissue contraction, making it the first and only of its kind on the market. In this blog, we will explore the benefits and possibilities that Morpheus8 offers, as well as the recent advancements that have further enhanced this already highly effective technology.
Innovative technology
Morpheus8 is the first and only fractional radiofrequency (FRF) microneedling technology cleared for contraction of soft tissue.
The U.S. Food and Drug Administration (FDA) has cleared the use of the Morpheus8 Applicators for the delivery of fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is needed. This FDA action expands Morpheus8’s existing FDA clearance, emphasizing the versatility of the technology for physicians and patients.
Coinciding with this clearance is the launch of the new IgniteRF and OptimasMAX platforms, which include the Morpheus8 family of handpieces. The modular portfolio of tips, including Prime 12 pin, Morpheus8 24 pin, Resurfacing 24 pin, and Morpheus8 40 pin, makes this technology a versatile solution delivering exceptional patient results. The IgniteRF and OptimasMAX platforms support 14 technologies, including minimally invasive radiofrequency assisted soft tissue coagulation and contraction, non-invasive thermal radiofrequency, intense pulsed light skin treatments, and multi-wavelength hair reduction.
Taken from the website: https://www.prnewswire.com/news/inmode-ltd./
For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
“InMode is dedicated to investing in R&D so we can provide medical professionals with continued advancements they need to deliver the highest quality of care and best-in-class results,” said Moshe Mizrahy, CEO of InMode. “The new indication for soft tissue contraction enhances the product’s intended use, helping Morpheus8 practitioners expand their patient base.”
Since inception, Morpheus8 has gained widespread global brand awareness, with more than 2.5 million procedures performed worldwide, and an average of 8.2 treatments performed every minute. The Morpheus8 brand has become so popular that consumers and celebrities request it by name. It is a trusted procedure known for delivering both natural and striking results.
The standard in aesthetic medicine
The Morpheus8 technology represents a significant advancement in the world of aesthetic surgery, enabling physicians to provide their patients with effective, safe, and minimally invasive treatments. Its FDA approval for soft tissue contraction further validates its value and reliability. With continuous innovations and enhancements, such as the new IgniteRF and OptimasMAKS platforms, Morpheus8 continues to set industry standards.
Morpheus8 at the Georgijev Clinic
At our Georgijev Center for Aesthetic Surgery and Anti-Aging Medicine, we take pride in offering advanced technologies like Morpheus8 that deliver natural and impressive results, meeting the needs and expectations of our patients.
Morpheus8 enhances the surgeon’s expertise by providing surgical precision and yielding superior outcomes through the integration of various treatments and procedures.
For more information about the treatment itself, click the button below or contact our Call Center.
